The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
Abstract
BACKGROUND: Screening for cervical cancer based on testing for human papillomavirus (HPV) increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia, but whether this gain represents overdiagnosis or protection against future high-grade cervical epithelial neoplasia or cervical cancer is unknown. METHODS: In a population-based screening program in Sweden, 12,527 women 32 to 38 years of age were randomly assigned at a 1:1 ratio to have an HPV test plus a Papanicolaou (Pap) test (intervention group) or a Pap test alone (control group). Women with a positive HPV test and a normal Pap test result were offered a second HPV test at least 1 year later, and those who were found to be persistently infected with the same high-risk type of HPV were then offered colposcopy with cervical biopsy. A similar number of double-blinded Pap smears and colposcopies with biopsy were performed in randomly selected women in the control group. Comprehensive registry data were used to follow the women for a mean of 4.1 years. The relative rates of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected at enrollment and at subsequent screening examinations were calculated. RESULTS: At enrollment, the proportion of women in the intervention group who were found to have lesions of grade 2 or 3 cervical intraepithelial neoplasia or cancer was 51% greater (95% confidence interval [CI], 13 to 102) than the proportion of women in the control group who were found to have such lesions. At subsequent screening examinations, the proportion of women in the intervention group who were found to have grade 2 or 3 lesions or cancer was 42% less (95% CI, 4 to 64) and the proportion with grade 3 lesions or cancer was 47% less (95% CI, 2 to 71) than the proportions of control women who were found to have such lesions. Women with persistent HPV infection remained at high risk for grade 2 or 3 lesions or cancer after referral for colposcopy. CONCLUSIONS: The addition of an HPV test to the Pap test to screen women in their mid-30s for cervical cancer reduces the incidence of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected by subsequent screening examinations. (ClinicalTrials.gov number, NCT00479375 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Cuzick, J., Clavel, C., Petry, K., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P., Kulasingam, S., Sasieni, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Diagnostic Cytology and Its Histopathologic Bases.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1341_1 · Cited by 775
Jacobs, M. V., Snijders, P. J., van den Brule, A. J., Helmerhorst, T. J., Meijer, C. J., & Walboomers, J. M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.791-795.1997 · Cited by 568
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00418-6 · Cited by 562
Wright, T. C., Schiffman, M., Solomon, D., Cox, J. T., Garcia, F., Goldie, S., Hatch, K., Noller, K. L., Roach, N., Runowicz, C., et al. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000109426.82624.f8 · Cited by 499
Wallin, K.-L., Wiklund, F., Ångström, T., Bergman, F., Stendahl, U., Wadell, G., Hallmans, G., & Dillner, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412201 · Cited by 493
Self-citationSherman, M. E., Lorincz, A. T., Scott, D. R., Wacholder, S., Castle, P. E., Glass, A. G., Mielzynska-Lohnas, I., Rush, B. B., & Schiffman, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.46 · Cited by 430
Ronco, G., Segnan, N., Giorgi-Rossi, P., Zappa, M., Casadei, G. P., Carozzi, F., Palma, P. D., Del Mistro, A., Folicaldi, S., Gillio-Tos, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj209 · Cited by 313
Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study
Evander, M., Edlund, K., Gustafsson, A., Jonsson, M., Karlsson, R., Rylander, E., & Wadell, G. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.1026 · Cited by 306
Self-citationBulkmans, N. W. J., Rozendaal, L., Snijders, P. J. F., Voorhorst, F. J., Boeke, A. J. P., Zandwijken, G. R. J., van Kemenade, F. J., Verheijen, R. H. M., v Groningen, K., Boon, M. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20076 · Cited by 269
Cuschieri, K. S., Cubie, H. A., Whitley, M. W., Seagar, A. L., Arends, M. J., Moore, C., Gilkisson, G., & McGoogan, E. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.57.1.68 · Cited by 267
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Dalla Palma, P., Del Mistro, A., De Marco, L., De Lillo, M., Naldoni, C., Pierotti, P., Rizzolo, R., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70731-8 · Cited by 225
Trends in cancer of the cervix uteri in Sweden following cytological screening
Bergström, R., Sparén, P., & Adami, H.-O. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690666 · Cited by 220
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial
on behalf of the ARTISTIC Trial Study Group, Kitchener, H. C., Almonte, M., Wheeler, P., Desai, M., Gilham, C., Bailey, A., Sargent, A., & Peto, J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603210 · Cited by 204
Mayrand, M., Duarte‐Franco, E., Coutlée, F., Rodrigues, I., Walter, S. D., Ratnam, S., Franco, E. L., & for the CCCaST Study Group (2006) · International Journal of Cancer · doi:10.1002/ijc.21897 · Cited by 122
Kotaniemi‐Talonen, L., Nieminen, P., Anttila, A., & Hakama, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602799 · Cited by 121
Clavel, C., Cucherousset, J., Lorenzato, M., Caudroy, S., Nou, J.-M., Nazeyrollas, P., Polette, M., Bory, J. P., Gabriel, R., Quereux, C., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601726 · Cited by 85
Forslund, O., Antonsson, A., Edlund, K., van den Brule, A., Hansson, B. G., Meijer, C. J. L. M., Ryd, W., Rylander, E., Strand, A., Wadell, G., et al. (2002) · Journal of Medical Virology · doi:10.1002/jmv.2178 · Cited by 75
Self-citationElfgren, K., Rylander, E., Rådberg, T., Strander, B., Strand, A., Paajanen, K., Sjöberg, I., Ryd, W., Silins, I., & Dillner, J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.056 · Cited by 71
Self-citationBulkmans, N. W. J., Rozendaal, L., Voorhorst, F. J., Snijders, P. J. F., & Meijer, C. J. L. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602541 · Cited by 65
Hoyer, H., Scheungraber, C., Kühne-Heid, R., Teller, K., Greinke, C., Leistritz, S., Ludwig, B., Dürst, M., & Schneider, A. (2005) · International Journal of Cancer · doi:10.1002/ijc.20955 · Cited by 40
Overdiagnosis and breast cancer screening
Day, N. E. (2005) · Breast Cancer Research · doi:10.1186/bcr1321 · Cited by 31
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Self-citationScreening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.10897 · Cited by 1,409
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Human papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
Metadata
- Authors
- Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., Hansson, B.-G., Rylander, E., & Dillner, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-10-18
- Volume
- 357
- Issue
- 16
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1980750660
- Cited by
- 797
- References
- 23
- FWCI
- 43.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.